Model NO.: 1421373-66-1
Category: Anti-Cancer
Trademark: Biocar
Transport Package: Foil Bag or Drums
Specification: 10g, 1kg
Origin: Wuhan, Hubei, China
HS Code: 0000000000
Model NO.: 1421373-66-1
Category: Anti-Cancer
Trademark: Biocar
Transport Package: Foil Bag or Drums
Specification: 10g, 1kg
Origin: Wuhan, Hubei, China
HS Code: 0000000000
99.62% Yellow Powder Azd-9291 Mesylate for Lung Cancer CAS 1421373-66-1
Quick info.
AZD-9291Â (Mesylate)Â Â
Product Name:  AZD-9291 (Mesylate)
CAS: Â 1421373-66-1
MF: Â C28H33N7O2.CH4O3S
Product Categories:  AZD09Â
| Anticancer |
| Azd-9291Â Mesylate/Osimertinib |
1421373-66-1 |
XL-184 Malate/Cabozantinib Malate |
1140909-48-3 |
| E7080 Mesylate/Lenvatinib Mesylate |
857890-39-2 |
AZD6244/Â Selumetinib |
606143-52-6 |
| AZD3759 |
1626387-80-1 |
INC280/Benzamide |
1029712-80-8 |
| Vemurafenib |
918504-65-1 |
Neratinib |
698387-09-6 |
| Dabrafenib Mesylate |
1195768-06-9 |
Olaparib |
763113-22-0 |
| MK1775 |
955365-80-7 |
Crizotinib |
877399-52-5 |
| AP26113 |
1197958-12-5 |
LYÂ 2157299/Galunisertib |
700874-72-2 |
Â
Main Functions:Â
AZD 9291 is an irreversible inhibitor of epidermal sensitizing and T790M resistance mutations (IC50s = 15-17 nM) while sparing the wild-type form of the receptor (IC50 = 480 nM). AZD 9291 has been shown to inhibit tumor growth in a xenograft mouse model at oral doses of 5-10 mg/kg and has been tested clinically in patients with advanced EGFR mutant non-small-cell lung cancer.
Â
99.62% Yellow Powder Azd-9291 Mesylate for Lung Cancer CAS 1421373-66-1
Quick info.
AZD-9291Â (Mesylate)Â Â
Product Name:  AZD-9291 (Mesylate)
CAS: Â 1421373-66-1
MF: Â C28H33N7O2.CH4O3S
Product Categories:  AZD09Â
| Anticancer |
| Azd-9291Â Mesylate/Osimertinib |
1421373-66-1 |
XL-184 Malate/Cabozantinib Malate |
1140909-48-3 |
| E7080 Mesylate/Lenvatinib Mesylate |
857890-39-2 |
AZD6244/Â Selumetinib |
606143-52-6 |
| AZD3759 |
1626387-80-1 |
INC280/Benzamide |
1029712-80-8 |
| Vemurafenib |
918504-65-1 |
Neratinib |
698387-09-6 |
| Dabrafenib Mesylate |
1195768-06-9 |
Olaparib |
763113-22-0 |
| MK1775 |
955365-80-7 |
Crizotinib |
877399-52-5 |
| AP26113 |
1197958-12-5 |
LYÂ 2157299/Galunisertib |
700874-72-2 |
Â
Main Functions:Â
AZD 9291 is an irreversible inhibitor of epidermal sensitizing and T790M resistance mutations (IC50s = 15-17 nM) while sparing the wild-type form of the receptor (IC50 = 480 nM). AZD 9291 has been shown to inhibit tumor growth in a xenograft mouse model at oral doses of 5-10 mg/kg and has been tested clinically in patients with advanced EGFR mutant non-small-cell lung cancer.
Â